Markers of Progression in Dementia with Lewy Bodies

Researchers at University College London are investigating markers of progression in DLB.

The aim is identify blood tests and brain markers that can help with monitoring progression. This will help make trials of new treatments more effective.

What will it involve?

Two visits to University College London: One at baseline, and another one year later.

At each visit you will have the following:

Thinking and memory tests

Clinical scales

MRI brain scan

Blood test

Who do the researchers need?

40 people with DLB who are able to get to London and are comfortable with a brain scan.

Who is funding this study?

This study is funded by grants from the British Medical Association and from a National Institute for Health Research Biomedical Centre Fast-track grant.

Interested in taking part?

Please contact Dr Rohan Bhome who is part of the study team (rohan.bhome@ucl.ac.uk)

or Dr Rimona Weil (r.weil@ucl.ac.uk) who is leading the study.

The team will get in contact if you are interested and explain more details about the study.

They will also go through screening questions before you take part.